Doloromics evensions a world without pain where precision medicines alleviate human suffering.
Our team of the world's leading pain experts is developing novel therapeutics using our proprietary platform that is built on a foundation of datasets of human neuronal tissues.
Effective treatments for pain are not making it to patients that suffer because therapeutics are failing to target underlying mechanisms.
Using a human-first approach, Doloromics has built a proprietary computational and human cell-based platform, DOLOReS, to identify targets and develop precision therapeutics that target pain at the source.
Chief Executive Officer
Chief Scientific Officer
Chief Research and Development Officer
Chief Business Officer
Head Research Scientist